Table IV. Differentially expressed GC cell envelope proteins identified by iTRAQ.
Accession | Name | Gene | Average ratio ± S.D.a |
Sb | Tc | ||
---|---|---|---|---|---|---|---|
F62:FA1090 | MS11:FA1090 | 1291:FA1090 | |||||
Outer membrane | |||||||
Q5F726 | Multidrug efflux pump channel protein | mtrE/NGO1363 | 1.08 ± 0.04 | 2.65 ± 0.02 | 0.93 ± 0.15 | Y | N |
Q5F6Q4 | Transferrin-binding protein A | tbpA/NGO1495 | 2.93 ± 0.25 | 0.83 ± 0.09 | 0.67 ± 0.07 | Y | N |
Periplasmic | |||||||
Q5F9E2 | Putative type IV pilin-like protein | NGO0456 | 0.14 ± 0.04 | 1.11 ± 0.11 | 0.98 ± 0.05 | N | N |
Q5F724* | Antibiotic resistance efflux pump component MtrCd | mtrC/NGO1365 | 0.93 ± 0 | 2.98 ± 0.39 | 0.28 ± 0.06 | Y | Y |
Inner membrane | |||||||
Q5F725 | Antibiotic resistance efflux pump component | mtrD/NGO1364 | 1.08 ± 0.01 | 3.21 ± 0.51 | 0.69 ± 0.02 | N | N |
Unknown | |||||||
Q5F5N1 | Lipoprotein | NGO1889 | 2.56 ± 0.09 | 2.4 ± 0.45 | 3.35 ± 0.02 | N | N |
Q5F865 | Putative peroxiredoxin family protein/glutaredoxin | NGO0926 | 0.39 ± 0.1 | 0.35 ± 0.11 | 0.27 ± 0.07 | N | N |
Q5F9E4 | Type IV pilus assembly protein PilW | pilW/NGO0454 | 0.34 ± 0.09 | 0.24 ± 0.02 | 0.26 ± 0.06 | N | N |
Cytoplasmic | |||||||
Q5F5Q8 | Elongation factor Tu | tuf1/NGO1842 | 0.41 ± 0.1 | 0.24 ± 0.03 | 0.3 ± 0.03 | N | N |
Q5F5T6 | 30S ribosomal protein S17 | rpsQ/NGO1830 | 0.64 ± 0.23 | 0.41 ± 0.04 | 0.45 ± 0.02 | N | N |
Q5F5V3 | 50S ribosomal protein L17 | rplQ/NGO1817 | 3.65 ± 0.07 | 1.7 ± 0.16 | 1.4 ± 0.05 | N | Y |
a Average ratio and standard deviation were calculated for differentially expressed proteins identified in both biological replica experiments with associated p < 0.05.
b Predictions of signal peptide cleavage site using SignalP server (47).
c Presence of twin-arginine signal peptide as determined by TatP (48).
d MtrC protein has been shown to be localized to the periplasm (111).